With over 25 years of design performance, over 1,000 peer-reviewed articles, and well over 1.5 million implants worldwide, the St. Jude Medical® mechanical valve with its proprietary pivot guard design delivers significant clinical advantages.
with Gelweave Valsalva Technology
Renowned Clinical Performance
Time-Tested Unique Pivot Guard Design
- Allows for upstream placement of leaflets resulting in an 85° opening angle2
- St. Jude Medical heart valve with proprietary pivot guard design; the subject of over 1,000 peer-reviewed articles and over 1.5 million implants
Outstanding Hemodynamic Performance
- 33% larger effective orifice area4 *
- Results in lower pressure gradients5,6,7
- Minimizes the potential for patient prosthesis mismatch5,6,8,9
- Expanded cuff - 15% more cuff than standard HP cuff10
- Promotes ease of suturing
- Conforms to the annulus
Gelweave Valsalva Technology
Ease of Implantation
- Patented Valsalva design
- Mimics natural anatomy11
- Provides up to 30% horizontal compliance12
- Eases suturing and reduces tension on coronaries11,12,13
- Reduces anastomotic site bleeding11,12,13
Gelweave Technology
- Minimally cross-linked gelatin aids in tissue ingrowth14
- Low porosity graft enables zero pre-clotting14
- Woven polyester fabric promotes healing14
* 25 mm Masters HP Valved Graft compared to a 25 mm Masters Valved Graft
Time-Tested Unique Pivot Guard Design
- Allows for upstream placement of leaflets resulting in an 85° opening angle2
- St. Jude Medical heart valve with proprietary pivot guard design; the subject of over 1,000 peer-reviewed articles and over 1.5 million implants
Optimal Cuff Configuration
- Offers excellent implantability
- Conforms to the annulus
Hemashield Technology
Proven Graft Technology
- Collagen impregnation provides uniform tissue ingrowth and biocompatibility3
- Low porosity graft eliminates the need for pre-clotting and reduces surgical time3
- Double-velour woven fabric offers excellent sealing, handling, and healing
- No pleats at the cuff to graft interface allows for easy positioning and attachment of coronaries
View list of heart valve model numbers.
1Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease nativeand prosthetic:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest. 2004 Sep;126(3Suppl):457S-482S.
2Shipkowitz T, Ambrus J, Kurk J,Wickramasinghe K.Evaluation technique for bileaflet mechanical valves. J Heart Valve Dis. 2002Mar;11(2):275-82.
3From manufacturer’s literature: Boston Scientific.
4Otto CM. Echocardiographic evaluation of prosthetic valve dysfunction. InOtto CM(ed) Textbook of Clinical Echocardiography. 2nd Ed. WB Saunders Co., Philadelphia,2000:310.
5Zingg U, Aeschbacher B, Seiler C, et al. Early experience with the new Masters series of St. Jude Medical heart valve: in vivo hemodynamic and clinical results in patients with narrowed aortic annulus. J Heart Valve Dis. 1997 Sep;6(5):535-41.
6Vitale N, Caldarera I, Muneretto C, et al. Clinical evaluation of St Jude Medical Hemodynamic Plus versus standard aortic valve prostheses: The Italian multicenter, prospective, randomized study. J Thorac Cardiovasc Surg. 2001 Oct;122(4):691-8.
7Carrel T, Zingg U, Jenni R, et al. Early in vivo experience with the Hemodynamic Plus St. Jude Medical heart valves in patients with narrowed aortic annulus. Ann Thorac Surg. 1996 May;61(5):1418-22.
8Natsuaki M, Itoh T, Okazaki Y, et al. Influence of St. Jude medical valve in patients with aortic stenosis and small aortic annulus on cardiac function and late survival result. Artif Organs. 2002 Oct;26(10):840-6.
9Urbanski PP, Dinstak W, Frank S, et al. Modified versus standard mechanical valved aortic conduit. Asian Cardiovasc Thorac Ann. 2005 Mar;13(1):53-7.
10From Manufacturer’s literature: St. Jude Medical, Inc.
11De Paulis R, De Matteis GM, Nardi P, et al. A new aortic Dacron conduit for surgical treatment of aortic root pathology. Ital Heart J. 2000 Jul;1(7):457-63.
12De Paulis R, Bassano C, Scaffa R, et al. Bentall procedures with a novel valved conduit incorporating "sinuses of Valsalva". Surg Technol Int. 2004;12:195-200.
13De Paulis R, De Matteis GM, Nardi P, et al. One-year appraisal of a new aortic root conduit with sinuses of Valsalva. J Thorac Cardiovasc Surg. 2002 Jan;123(1):33-9.
14From manufacturer’s literature: Vascutek Ltd.